| Model Number |
PED2-400-25 |
| Medical Device Problem Codes |
Break (1069); Unintended Ejection (1234)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
02/17/2026
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Medtronic received report that during unsheathing of the pipeline shield, it was noticed that the tip coil was migrated inside the stent and not in the proper expected location.It was noted that the pipeline and all accessory devices were prepared as indicated in the instructions for use (ifu).The pipeline was removed and replaced to complete the procedure.There was no harm or injury to the patient who was undergoing a procedure for flow diverter treatment of an internal carotid artery (ica) unruptured saccular aneurysm.The aneurysm max diameter was 4mm and the neck diameter was 4mm.The distal landing zone was 2.6mm; the proximal landing zone was 4.15mm.Vessel tortuosity was moderate.
|
| |
|
Additional Manufacturer Narrative
|
|
H2: review of this mdr and/or additional information received shows that there is no information to reasonably suggest that the device in this report may have caused or contributed to a death or serious injury or that the device in this report has a reportable malfunction.Therefore, this event did not and does not meet the reporting requirements stipulated in 21 cfr 803.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
B5: additional information added to event summary.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Additional information was received reporting that the event occurred during deployment.It is not confirmed if it was pushed or rotated.
|
| |
|
Search Alerts/Recalls
|